Shifting views on lipid lowering therapy.
Krumholz
Harlan M
HM
Department of Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. harlan.krumholz@yale.edu
Hayward
Rodney A
RA
D008078:Cholesterol, LDL / Q000097:blood; D003324:Coronary Artery Disease / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D012016:Reference Values; D040242:Risk Reduction Behavior
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents